OPM Biosciences

Shanghai OPM Biosciences Co., Ltd. is a high-tech biotechnology company specializing in providing cell culture solutions and end-to-end CDMO services, committed to helping partners accelerate the process of innovative drugs from gene (DNA) to clinical trial application (IND), to production of clinical trial drugs, and to GMP-compliant commercial production, minimizing the overall drug cost.
Our brand OPM® provides serum-free cell culture media, including self-developed commercial media, customized media, and media contract manufacturing services. The Sureness® end-to-end CDMO service platform provides services from gene sequence, stable cell line development, upstream and downstream process development, formulation process development, GMP-compliant pilot production (200L/500L), and NMPA, FDA, EMA preclinical applications (IND) as well as production of clinical trial drugs.
Since its establishment in 2013 in the International Medical Park of Zhangjiang Science City, OPM has continuously optimized and innovated, relying on an excellent R&D team and a complete commercial production quality management system. Adhering to the core principles of providing diversified, high-performance, and highly stable products, and maintaining a service attitude of rapid response and continuous improvement, we offer partners stable, reliable, and customized cell culture media as well as end-to-end CDMO solutions.